Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (74)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ashby, J.
Right arrow Articles by Tennant, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ashby, J.
Right arrow Articles by Tennant, R. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Mutagenesis vol. 9 no. 1 pp. 7-15, 1994
© 1994 UK Environmental Mutagen Society/Oxford University Press


research-article

Prediction of rodent carcinogenicity for 44 chemicals: results

J. Ashby1 and R. W. Tennant2

1Zeneca Central Toxicology Laboratory Alderley Park, Macclesfield, Cheshire, SK10 4JT, UK 2National Institute of Environmental Health Sciences, Research Triangle Park NC 27709, USA

Methods by which rodent carcinogenicity can be predicted have been prospectively validated for 40 chemicals evaluated for carcinogenicity by the US National Toxicology Program. It is concluded that a chemical of unknown carcinogenicity can be predicted to be in one of three possible categories probably carcinogenic, probably non-carcinogenic or of uncertain activity. The last category is unlikely to contain genotoxic trans-species and/or multiple-site carcinogens. The component parameters of such predictions are one or more of several aspects of chemical structure, genotoxicity and rodent toxicity. Each of these parameters requires refinement but all are developed to the point that they can be integrated to make assessment of possible carcinogenicity. Carcinogenicity tends to be overpredicted by this integrated technique, each part of which has already been simulated by computer modelling. Improvements in predictive methodology will flow from three assumptions: (i) that emphasis must be placed equally on the properties of the test chemical and the responses it elicits in tissues for which carcinogenicity is to be predicted, (ii) that the integration of different predictive techniques is preferrable to the exclusive use of a single technique, and (iii) that the general predictivity of any technique or combination of techniques appears to be limited to ≤80%, imposed by inadequate knowledge, and uncertainties in the experimental evaluation and classification of carcinogenic responses for diverse chemicals. This last statement does not preclude the attainment of higher accuracy within a congeneric series of chemicals. Foreknowledge of the likely outcome of a rodent carcinogenicity bioassay is now possible and will contribute to the focusing of animal testing resources.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol PatholHome page
D.G. Allen, G. Pearse, J.K. Haseman, and R.R. Maronpot
Prediction of Rodent Carcinogenesis: An Evaluation of Prechronic Liver Lesions as Forecasters of Liver Tumors in NTP Carcinogenicity Studies
Toxicol Pathol, June 1, 2004; 32(4): 393 - 401.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
K. S. Mcdorman and D. C. Wolf
Use of the Spontaneous Tsc2 Knockout (Eker) Rat Model of Hereditary Renal Cell Carcinoma for the Study of Renal Carcinogens
Toxicol Pathol, October 1, 2002; 30(6): 675 - 680.
[Abstract] [PDF]


Home page
MutagenesisHome page
N. F. Cariello, J. D. Wilson, B. H. Britt, D. J. Wedd, B. Burlinson, and V. Gombar
Comparison of the computer programs DEREK and TOPKAT to predict bacterial mutagenicity
Mutagenesis, July 1, 2002; 17(4): 321 - 329.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
G. S. Omenn
Assessment of Human Cancer Risk: Challenges for Alternative Approaches
Toxicol Pathol, January 1, 2001; 29(1_suppl): 5 - 12.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
H. E. Holden, R. E. Stoll, and K. T. Blanchard
Oxymetholone: II. Evaluation in the Tg.AC Transgenic Mouse Model for Detection of Carcinogens
Toxicol Pathol, September 1, 1999; 27(5): 507 - 512.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
C. Walker
Molecular Genetics of Renal Carcinogenesis
Toxicol Pathol, January 1, 1998; 26(1): 113 - 120.
[Abstract] [PDF]


Home page
Hum Exp ToxicolHome page
J. Ashby
Alternatives to the 2-species bioassay for the identification of potential human carcinogens
Human and Experimental Toxicology, March 1, 1996; 15(3): 183 - 202.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.